Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
Health Canada is informing Canadians and healthcare professionals about changes to the product labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines.The Department is updating the label of the Janssen COVID-19 Vaccine to provide additional information about the very rare risk of immune thrombocytopenia (ITP), an autoimmune condition, and the rare risk of venous thromboembolism...
Ivermectin not authorized to prevent or treat COVID-19; It may cause serious health problems
Health Canada has received concerning reports of the use of veterinary ivermectin to prevent or treat COVID-19. Canadians should never consume health products intended for animals because of the potential serious health dangers posed by them. In this light, Health Canada is advising Canadians not to use either the veterinary or human drug versions of...
Third dose of COVID-19 Vaccine
Flu and COVID-19 Differences
Vaccines for COVID-19
How to book a COVID-19 vaccine appointment
Clarification on WHO statement about COVID-19 vaccine interchangeability
The media has recently reported that a physician associated with the World Health Organization (WHO) suggested that the mixing of vaccines was a ‘dangerous trend’. This was not an official statement by the World Health Organization. The statement was made at a session unrelated to vaccine mixing and was taken out of context by news...
Real World Evidence for COVID-19 Vaccines
Similar to clinical trials, real world cohort and case-control studies find COVID-19 infections are reduced by >90% with two doses of mRNA vaccines. Single doses of either mRNA or AstraZeneca vaccine decreases infections by ~60% and hospitalizations by 70-80%. Vaccine effectiveness appears similar for variants of concern and are safe for pregnant women. HMC
Second dose of COVID-19 Vaccination
NACI has provided updated recommendations on COVID-19 vaccine schedules. For those who have received a first dose of an AstraZeneca vaccine, an mRNA vaccine is preferred for the second dose due to emerging evidence suggesting better immune response, and, to mitigate the risk of VITT(Vaccine-Induced Thrombotic Thrombocytopenia) from viral vector vaccines. HMC
Since May 2021, the Public Health Agency of Canada has been actively monitoring reports of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines through passive and active Canadian safety surveillance systems. Available information from international reports, including those from Israel and the United States, indicated that: cases were more commonly reported after the second dose, and...
COVID-19 Second Dose Booking
Residents aged 70 and over, as well as those who received the first dose of an mRNA COVID-19 vaccine on or before April 18, 2021 are now able to book their second dose appointments. The provincial booking system will allow these individuals to book appointments as of Monday, June 7, 2021 at 8:00 am. This...
Second Dose COVID-19 Vaccine Type-Interchangeability, Updated on June3, 2021
NACI recommends that persons who received a first dose of the AstraZeneca/COVISHIELD vaccine may receive either AstraZeneca/COVISHIELD vaccine or an mRNA vaccine (Pfizer-BioNTech or Moderna) for their second dose, unless contraindicated. On June 1, the Public Health Agency of Canada released updated recommendations from the National Advisory Committee on Immunization (NACI) on the interchangeability of authorized...
After you are vaccinated, you can log in to the provincial portal to download or print an electronic COVID-19 Vaccine receipt for each dose you have received. Receipts are available: for first and second doses received in Ontario (once you get them) regardless of where you were vaccinated (for example, at a mass immunization clinic,...
AstraSeneca Second Dose
At this time, the National Advisory Committee on Immunization (NACI) does NOT recommend that vaccines of different types (e.g., mRNA vaccine and viral vector vaccine) be used in the two-dose series, as data on the immune response following mixed vaccine schedules are not yet available. Further information from clinical trials and NACI’s recommendation are anticipated...
Receiving the COVID-19 Vaccine after CPVID-19 infection
Peel Public Health has confirmed with the Ministry of Health Emergency Operations centre that individuals with a previous COVID-19 infection may receive their COVID-19 vaccination at any time after they have recovered as long as they have completed self-isolation and have been symptom-free for at least 24 hours. HMC
Youth aged 12-17 will be eligible to register to receive the Pfizer COVID-19 vaccine as of May 31
Stay in contact with Peel Public Health for further details. HMC
COVID-19 and Maintaining Mental Health Hygiene
Please look at the link added to our website to increase your resilience during tough time of COVID-19 pandemic. https://howdenmedicalclinic.com/wp-content/uploads/2021/05/Maintaining-Mental-Health-Hygiene-1.pd HMC
All Peel residents aged 18+ are now eligible to receive their COVID-19 vaccine
Effective May 6, all Peel residents aged 18 or older are eligible for vaccination, including those who do not live in provincially designated hot spots. Please note that in order to be eligible, individuals must be at least 18 years of age at the time of their vaccination. Eligible residents can book appointments at any of Peel...
COVID vaccination for 45 years old and older individuals
As of April 27th, 2021, all individuals who are 45 and over who live in a hot spot postal code, will be eligible to book their COVID-19 vaccine appointment. HMC